Task: Answer the multiple-choice question.
Query: Which drug exhibits a -2.087% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a: COC(=O)NCc1ccc(CNC(=O)OC)cc1
b: CCN(CC)C(=O)C(C)OC(=O)c1ccc(O)cc1
c: CCC(=O)NCCCOc1ccccc1
d: CCCCOC(=O)c1cc(C)nc2ccc(Br)cc12
e: CSc1ccc(/C=N/n2c(C)cc(C)cc2=O)cc1
Answer: e. CSc1ccc(/C=N/n2c(C)cc(C)cc2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSc1ccc(/C=N/n2c(C)cc(C)cc2=O)cc1
CSc1ccc(/C=N/n2c(C)cc(C)cc2=O)cc1
4,6-dimethyl-1-[(E)-(4-methylsulfanylphenyl)methylideneamino]pyridin-2-one